[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lifestyle-alteration\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lifestyle-alteration":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":4},"100634103","exercise-targeted-smart-lifestyle-management-100634103",false,"NCT07535333","Exercise-Targeted Smart Lifestyle Management","Study on the Improvement Effects of Intelligent Lifestyle Management, Targeting Exercise Capacity Enhancement, on Overweight\u002FObesity With Metabolic Syndrome","Inclusion Criteria:\n\n* Aged between 20 and 60 years.\n* Overweight or obese, with a Body Mass Index (BMI) ≥ 24 kg\u002Fm² and \\\u003C 40 kg\u002Fm².\n* Patients with impaired metabolic parameters regarding glucose, lipids, and blood pressure，meet at least two of the following criteria:\n\n  * Central obesity: Waist circumference ≥ 90 cm for males or ≥ 85 cm for females.\n  * Hyperglycemia: Fasting plasma glucose (FPG) ≥ 6.1 mmol\u002FL, or 2-hour plasma glucose ≥ 7.8 mmol\u002FL during an oral glucose tolerance test (OGTT), and\u002For currently receiving treatment for previously diagnosed diabetes.\n  * Hypertension: Blood pressure ≥ 130\u002F85 mmHg, and\u002For currently receiving treatment for previously diagnosed hypertension.\n  * Elevated fasting triglycerides (TG): ≥ 1.7 mmol\u002FL.\n  * Reduced fasting high-density lipoprotein cholesterol (HDL-C): \\\u003C 1.04 mmol\u002FL.\n\nExclusion Criteria:\n\n* History of cardiovascular or cerebrovascular disease, or in the acute phase, including: angina pectoris, myocardial infarction, coronary revascularization surgery, stroke (ischemic or hemorrhagic, including transient ischemic attack), symptomatic peripheral artery disease requiring surgery or diagnosed via angiographic techniques, ventricular arrhythmias, uncontrolled atrial fibrillation, congestive heart failure (New York Heart Association class III or IV), hypertrophic cardiomyopathy, history of aneurysm with diameter ≥ 5.5 cm, or history of aneurysm surgery.\n* Malignancy or history of malignancy within the past five years.\n* Religious restrictions or dysphagia preventing adherence to the recommended diet.\n* Contraindications to exercise, such as orthopedic disorders.\n* Participation in other weight-loss programs (\\> 5 kg weight loss) within the six months prior to the screening visit.\n* History of bariatric surgery or intention to undergo bariatric surgery within the next 12 months.\n* History of small or large bowel resection or inflammatory bowel disease.\n* Obesity due to endocrine disorders of unknown cause (excluding treated hypothyroidism).\n* Allergy to any food components of the Mediterranean diet.\n* Immunodeficiency or HIV positive status.\n* Cirrhosis or liver failure.\n* Severe psychiatric disorders, including schizophrenia, bipolar disorder, eating disorders, or depression requiring hospitalization in the past 6 months.\n\nSevere comorbidities with a life expectancy of less than 24 months.\n\n* Alcoholism, addiction, or drug abuse in the past six months (or daily alcohol consumption \\> 50 g).\n* History of major organ transplantation.\n* Concomitant use of immunosuppressive or cytotoxic medications.\n* Current use of systemic corticosteroids.\n* Current use of weight-loss medications.\n* Currently participating in another randomized clinical trial.\n* Patients with acute infection or inflammation (e.g., pneumonia) may -participate 3 months after resolution of the condition.\n* Pregnant or planning to become pregnant during the study period.\n* Any other condition that may interfere with protocol compliance.\n* Refusal to sign the informed consent document.","ALL","20 Years","60 Years",{"count":20,"type":21},435,"ESTIMATED","INTERVENTIONAL",[24],"NA","To investigate the effects of simple dietary management and diet combined with exercise capacity-targeted intelligent lifestyle management on improving metabolic indicators in patients with overweight\u002Fobesity and metabolic syndrome.",[27,28,29,30,31],"M-health","Metabolic Syndrome","Lifestyle Alteration","Lifestyle (Sedentary Behavior and Physical Activity)","Overweight , Obesity",[33,28,34,35,31],"mhealth","Lifestyle (sedentary behavior and physical activity)","Mediterranean Diet","NOT_YET_RECRUITING","2026-04-09",{"date":39,"type":40},"2026-04-17","ACTUAL",{"date":42,"type":21},"2026-05",{"date":44,"type":21},"2027-06",{"name":46,"class":47},"China National Center for Cardiovascular Diseases","OTHER_GOV",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":60,"conditions":61,"keywords":67,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":85},"100603330","targeting-lifestyle-to-improve-colorectal-cancer-screening-100603330","NCT07135115","Targeting Lifestyle to Improve Colorectal Cancer Screening","KoloPrev","Inclusion Criteria:\n\n* Invited to the first round of immunochemical faecal blood testing in the national colorectal cancer screening program via a digital platform.\n\nExclusion Criteria:\n\n* Not invited to the national colorectal cancer screening program.","55 Years","56 Years",{"count":58,"type":21},16000,[24],"The goal of this study is to learn whether receiving personalized, digital lifestyle advice during colorectal cancer screening leeds to changes in lifestyle over a two-year follow-up period. Changes will be measured using a composite score including diet, alcohol consumption, physical activity, body mass index and smoking habits. The main questions it aims to answer are:\n\n* Do participants who receive short, personalized digital feedback on their lifestyle - either once or through repeated rounds -change their lifestyle during the two-year study period, compared to those who do not receive any feedback?\n* Does the inclusion of additional contact, such as telephone consultation with healthcare providers, result in further lifestyle changes?\n\nResearchers will compare three groups which receive digital feedback at different intensities and a control group which does not get any feedback to see if lifestyle changes differ between the groups.\n\nParticipants in four different groups will fill in a digital diet and lifestyle questionnaire at the start of the study and 2-4 times after this during the following 2 years.\n\n* Participants in three of the groups will receive a short digital feedback report on their lifestyle related to health recommendations after each completion of the questionnaire.\n* One of these groups will also be offered to go through the feedback report together with a healthcare provider in a telephone call.\n* This group will also receive invitations to motivational webinars every half year during the 2-year study period. The topics in the webinars address cancer preventive lifestyle.\n\nA secondary goal of the study is to understand whether the invitation to fill in the diet and lifestyle questionnaire affects participation in colorectal cancer screening. Therefore, a fifth group of individuals invited to colorectal cancer screening but not to be invited to fill in the questionnaire will be included for extra comparison. Participation in colorectal cancer screening will be compared between this group and the four groups that are additionally invited to complete the questionnaire.\n\nAnother secondary goal is to learn which groups in the society consent to the current study. Therefore, sociodemographic characteristics will be compared between the invited individuals who consent and those who do not consent to the study.",[29,62,63,64,65,66],"Tobacco","Diet Modification","Physical Activity","Alcohol Consumption","Body Weight Control",[68,69,70,71,72,73,74,75],"Lifestyle intervention","Colorectal cancer screening","Diet","Alcohol consumption","Smoking","Body mass index","Physical activity","Digital questionnaire","2025-08-26",{"date":78,"type":40},"2025-09-03",{"date":80,"type":21},"2025-10-15",{"date":82,"type":21},"2041-12-31",{"name":84,"class":47},"Norwegian Institute of Public Health",1]